Skip to main content
SpringerLink
Log in

Line Cell Saga — An Argument in Favor of Production of Biologics in Cancer Cells

  • Chapter
Cell Substrates

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 118))

Abstract

William Shakespeare observed that “All the world’s a stage and all the men and women merely players’.” This is no less true for those who act out the events of science than for thespians who pursue a career in the theater. It is amply illustrated in the drama that has attended the evolution of the dogma for acceptability or nonacceptability of particular kinds of cell cultures for preparing biologic products for use in man. Even cursory review leads to the conclusion that ill-conceived fears, preconceived notions, and personalities have contributed as much, perhaps, to decisionmaking as has science itself in this area of activity in which the scientific fact base is less than definitive.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hilleman, M. R. Cells, vaccines, and the pursuit of precedent. National Cancer Institute Monograph No. 29, pp 463–469. 1968.

    PubMed  CAS  Google Scholar 

  2. Hilleman, M.R. Cells, vaccines, and safety for man. Biohazards in Biological Research. Edited by A. Hellman, M.N. Oxman, R. Pollack. Cold Spring Harbor Laboratory, 1973, pp 81–95.

    Google Scholar 

  3. Hilleman, M.R. Prospects for vaccines against cancer. Viruses, Evolution and Cancer. Edited by E. Kurstak and K. Maramorosch. New York, Academic Press, Inc., 1974, pp 549–560.

    Google Scholar 

  4. Hilleman, M.R. and Werner J.H. Recovery of new agent from patients with acute respiratory illness. Proc. Soc. Exp. Biol. Med. 85:183–188, 1954.

    PubMed  CAS  Google Scholar 

  5. Biological Products, Public Health Service Regulations, Title 42, Part 73. U.S. Department of Health, Education, and Welfare, Publication 437 (revised Jan. 1967)

    Google Scholar 

  6. Hayflick, L. and Moorhead, P.S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25:585–621, 1961.

    Article  Google Scholar 

  7. Continuously cultured tissue cells and viral vaccines. Report of a committee on tissue culture viruses and vaccines. Science 139:15–20, 1963.

    Article  Google Scholar 

  8. Hayflick, L., Moorhead, P.S., Pomerat C.M. et al: Choice of a cell system for vaccine production. Science 140:766–768, 1963.

    Google Scholar 

  9. Sabin, A.B. Cancer and human cell vaccines. Science J A5:33, 1969.

    Google Scholar 

  10. Hayflick, L. Dangerous vaccines. Science J A5:33, 1969.

    Google Scholar 

  11. Sabin, A.B. Gamma globulin prophylaxis; inactivated rubella virus; production and biologics control of live attenuated rubella virus vaccines. Discussion on Session V. Amer. J. Dis. Child 118:378–381, 1969.

    Google Scholar 

  12. Perkins, F.T. and Hayflick, L. Cell cultures. Science 155: 723–724, 1967.

    Article  PubMed  CAS  Google Scholar 

  13. Andreopoulos, S. Human vaccines and bureaucracy: Stanford professor’s Odyssey. Stanford, MD 11:18–22, 1972.

    Google Scholar 

  14. Petricciani, J.C. Vaccine developments and the public interest. Stanford, MD 11:13–16, 1972.

    Google Scholar 

  15. Petricciani, J.C, Milstien, J.B., Seifried, A.S., et al. Safety of viral vaccine cell substrates: A reevaluation. J. Natl. Cancer Inst. 57:915–919, 1976.

    PubMed  CAS  Google Scholar 

  16. Petricciani, J.C, Hopps, H.E., and Lorenz, D.E. Human virus vaccines: Why monkey cells? Science 176:813–14, 1972.

    Article  Google Scholar 

  17. Minutes of the Third Meeting of the Committee on Cell Cultures, International Association of Microbiological Societies, Permanent Section of Microbiological Standardization, Philadelphia May 18, 1966.

    Google Scholar 

  18. Developments in Biological Standardization. Volume 37. Edited by F.T. Perkins and R.H. Regamey. Switzerland, S. Karger, 1977.

    Google Scholar 

  19. Girardi A.J., Sweet, B.H., Slotnick, V.B. et al Development of tumors in hamsters inoculated in the neonatal period with vacuolating virus, SV40. Proc. Soc. Exp. Biol. Med. 109: 649–660, 1962.

    CAS  Google Scholar 

  20. Gear J.S.S., Cassel G.A., Gear A.J., et al. Outbreak of Marburg virus disease in Johannesburg. British Med. J. 4: 489–493, 1975.

    Article  CAS  Google Scholar 

  21. Cockburn, W.C. Poliomyelitis vaccination in tropical countries. Advances in Experimental Medicine and Biology. Edited by A Kohn and M.A. Klingberg. New York, Plenum Press, 1972, pp 223–236.

    Google Scholar 

  22. Hilleman, M.R., Bertland, A.U., Buynak, E.B., et al Clinical and laboratory studies of hepatitis B surface antigen vaccine. Viral Hepatitis. Edited by G.N. Vyas, S.N. Cohen, and R. Schmid. Philadelphia, Franklin Institute Press, 1978.

    Google Scholar 

  23. MacNab, G.M, Alexander, J.J., Lecatsas, G., et al. Hepatitis B surface antigen produced by a human hepatoma cell line. Br. J. Cancer 34:509–515, 1976.

    Article  PubMed  CAS  Google Scholar 

  24. Memorandum: Interferon and other antiviral agents, with special reference to influenza. Bull WHO 56:229–240, 1978.

    Google Scholar 

  25. Hirsch, M.S. Interferon — its hour come at last? N. Eng. J. Med. 298:1022–1023, 1978.

    Article  CAS  Google Scholar 

  26. Merigan, T.C., Rand, K.H., Pollard, R.B., et al Human leukocyte interferon for the treatment of herpes zoster in patients with cancer. N. Eng. J. Med. 298:981–987, 1978.

    Article  CAS  Google Scholar 

  27. Strander, H. Mogensen, K.E., and Cantell, K. Production of human lymphoblastoid interferon. J. Clin. Microbiology 1: 116–117, 1975.

    CAS  Google Scholar 

  28. Zoon, K.C., Buckler, C.E., Bridgen, P.J., et al. Production of human lymphoblastoid interferon by Namalva cells. J. Clin. Microbiology 7:44–51, 1978.

    CAS  Google Scholar 

  29. Andersson-Anvret, M. and Lindahl, T. Integrated viral DNA sequences in Epstein-Barr virus-converted human lymphoma lines. J. Virology 25:710–718, 1978.

    PubMed  CAS  Google Scholar 

  30. Pagano, J.S. The Epstein-Barr viral genome and its interactions with human lymphoblastoid cells and chromosomes. Viruses, Evolution and Cancer. Edited by E. Kurstak and K. Maramorosch. New York, Academic Press, Inc., 1974, pp 79–116.

    Google Scholar 

  31. Pritchett, R., Pedersen, M., and Kieff, E. Complexity of EBV homologous DNA in continuous lymphoblastoid cell lines. Virology 74:227–231, 1976.

    Article  Google Scholar 

  32. Doerfier, W. Integration of the deoxyribonucleic acid of adenovirus type 12 into the deoxyribonucleic acid of baby hamster kidney cells. J. Virology 6:652–666, 1970.

    Google Scholar 

  33. Botchan, M., Topp, W., and Sambrook, J. The arrangement of Simian virus 40 sequences in the DNA of transformed cells. Cell 9:269–287, 1976.

    Article  PubMed  CAS  Google Scholar 

  34. Harnden, D.G. Chromosome abnormalities and predispostion towards cancer. Proc. Roy.Soc. Med. 69:41–43, 1976.

    PubMed  CAS  Google Scholar 

  35. Levan A., Levan, G., and Mitelman, F. Chromosomes and cancer. Hereditas 86:15–30, 1977.

    Article  PubMed  CAS  Google Scholar 

  36. Chromosomes and cancer. The Lancet ii:227–228, 1977.

    Google Scholar 

  37. Deoxyribonuclease I (Bovine pancreas). Worthington Enzyme Manual. Edited by L.A. Decker. New Jersey, Worthington Biochemical Corporation, 1977, pp 153–155.

    Google Scholar 

  38. Laskowski, M., Sr. Deoxyribonuclease I. The Enzymes. Third Edition. Edited by P.D. Boyer. New York, Academic Press, Inc., 1971, pp 289–311.

    Google Scholar 

  39. Smart, J.E. and Bonner, J. Studies on the role of histones in relation to the template activity and precipitability of chromatin at physiological ionic strengths. J. Mol. Biol 58:675–684. 1971.

    Article  PubMed  CAS  Google Scholar 

  40. Harper H.A., Rodwell, V.W., Mayes, P.A., et al. Protein synthesis and the genetic code. Review of Physiological Chemistry. Sixteenth Edition. California, Lange Medical Publications, 1977, pp 433–447.

    Google Scholar 

  41. Fleckenstein, B., Daniel, M.D., Hunt, R.D. et al. Tumour induction with DNA of oncogenic primate herpesviruses. Nature 274:57–59, 1978.

    Article  PubMed  CAS  Google Scholar 

  42. Sol, C.J.A. and van der Noordaa, J. Oncogenicity of SV40 DNA in the Syrian hamster. J. Gen. Virol. 37:635–638. 1977.

    Article  CAS  Google Scholar 

  43. Igarashi, K., Sasada, R., Kurokawa, T., et al. Biochemical studies on bovine adenovirus type 3. IV. Transformation by viral DNA and DNA fragments. J. Virol. 28:219–226. 1978.

    CAS  Google Scholar 

  44. Staehelin, M. Reaction of tobacco mosaic virus nucleic acid with formaldehyde. Biochimica et Biophysica Acta 29: 410–417, 1958.

    Article  PubMed  CAS  Google Scholar 

  45. Feldman, M.Y. Reactions of nucleic acids and nucleoproteins with formaldehyde. Progress in Nucleic Acid Research and Molecular Biology. Volume 13. Edited by J.N. Davidson and W.E. Cohn. New York, Academic Press, 1973. pp 1–49.

    Google Scholar 

  46. Sarkar, N.K. and Dounce, A.L. A spectroscopic study of the reaction of formaldehyde with deoxyribonucleic and ribonucleic acid. Biochimica et Biophysica Acta 49:160–169, 1961.

    Article  PubMed  CAS  Google Scholar 

  47. Pope, J.H., Horne, M.K., and Scott, W. Transformation of foetal human leukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus. Int. J. Cancer 3:857–866, 1968.

    Article  PubMed  CAS  Google Scholar 

  48. Katsuki, T. and Hinuma, Y. Characteristics of cell lines derived from human leukocytes transformed by different strains of Epstein-Barr virus. Int. J. Cancer 15:203–210, 1975.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Virus & Cell Biology Research, Merck Institute for Therapeutic Research, West Point, Pennsylvania, 19486, USA

    Maurice R. Hilleman Ph.D., D.Sc.

Authors
  1. Maurice R. Hilleman Ph.D., D.Sc.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Bureau of Biologics of the Food and Drug Administration, Bethesda, Maryland, USA

    John C. Petricciani  & Hope E. Hopps  & 

  2. W. Alton Jones Cell Science Center, Lake Placid, New York, USA

    Paul J. Chapple

Rights and permissions

Reprints and permissions

Copyright information

© 1979 Plenum Press, New York

About this chapter

Cite this chapter

Hilleman, M.R. (1979). Line Cell Saga — An Argument in Favor of Production of Biologics in Cancer Cells. In: Petricciani, J.C., Hopps, H.E., Chapple, P.J. (eds) Cell Substrates. Advances in Experimental Medicine and Biology, vol 118. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-0997-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-0997-0_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-0999-4

  • Online ISBN: 978-1-4684-0997-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation